Drug:
Reaction: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940363 |
US |
63 | 2 |
Migraine, Therapeutic response shortened, Inappropriate schedule of product administration, |
||||
GALCANEZUMAB-GNLM, |
||||
| 2 | 26940678 |
US |
2 | |
Gastrooesophageal reflux disease, Burning sensation, Dyspepsia, Feeling abnormal, Insomnia, Nausea, Arthralgia, Vomiting, Expired product administered, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 3 | 26940767 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
GUSELKUMAB, |
||||
| 4 | 26940843 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 5 | 26940849 |
US |
5 | 1 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 6 | 26941201 |
CN |
18 | 2 |
Palpitations, Nausea, Vomiting, Dizziness, Inappropriate schedule of product administration, Chest discomfort, Decreased appetite, |
||||
PIOGLITAZONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 7 | 26941286 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 8 | 26941314 |
US |
43 | 2 |
Eczema, Pruritus, Sleep disorder, Rash, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, RUXOLITINIB, |
||||
| 9 | 26941328 |
US |
1 | |
Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 10 | 26941444 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
GUSELKUMAB, |
||||
| 11 | 26941496 |
US |
64 | 2 |
Pain, Pain in extremity, Abdominal pain upper, Sleep disorder, Nausea, Palpitations, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, |
||||
| 12 | 26941571 |
CO |
2 | |
Neoplasm malignant, Inappropriate schedule of product administration, Drug ineffective, Laboratory test abnormal, |
||||
RIBOCICLIB, RIBOCICLIB, FULVESTRANT, DENOSUMAB, |
||||
| 13 | 26941572 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
TILDRAKIZUMAB-ASMN, |
||||
| 14 | 26941786 |
CA |
36 | |
Condition aggravated, Migraine, Anaphylactic reaction, Hypotension, Inappropriate schedule of product administration, Suspected off label use, |
||||
OMALIZUMAB, |
||||
| 15 | 26941795 |
CA |
47 | |
Haematochezia, Abdominal pain, Product distribution issue, Therapy interrupted, Inappropriate schedule of product administration, Therapeutic response shortened, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, MESALAMINE, MESALAMINE, |
||||
| 16 | 26941811 |
US |
1 | |
Therapy interrupted, Inappropriate schedule of product administration, Nasopharyngitis, COVID-19, |
||||
TILDRAKIZUMAB-ASMN, |
||||
| 17 | 26941842 |
US |
2 | |
Inappropriate schedule of product administration, Nausea, |
||||
TIRZEPATIDE, |
||||
| 18 | 26941872 |
CA |
53 | |
Cardiac murmur, Colitis ulcerative, Impaired quality of life, Pneumonia, Condition aggravated, Frequent bowel movements, Adverse drug reaction, Migraine, Blood cholesterol increased, Bronchiectasis, Hypopnoea, Pain in extremity, Rhinitis, Lymphocyte count decreased, Eczema, Parosmia, Steroid dependence, Abdominal discomfort, Gingival pain, Pulmonary embolism, Catarrh, COVID-19, Vertigo, Impaired work ability, Arthritis, Swollen tongue, Tubulointerstitial nephritis, Palpitations, Dysgeusia, Cerebrovascular accident, Nightmare, Pain, Deep vein thrombosis, Stress, Neutrophil count increased, Monocyte count decreased, C-reactive protein increased, Haemoglobin decreased, Platelet count increased, Haematocrit decreased, Haematochezia, Uterine leiomyoma, Gamma-glutamyltransferase increased, Red cell distribution width increased, Mean cell haemoglobin concentration decreased, Red blood cell count decreased, Mean platelet volume decreased, Depression, Systemic lupus erythematosus, Abdominal lymphadenopathy, Confusional state, Headache, Tinnitus, Somnolence, Rash, Hypersensitivity, Rectal haemorrhage, Pyrexia, Weight decreased, Burns second degree, Alcohol poisoning, Inappropriate schedule of product administration, Product use in unapproved indication, Off label use, Drug ineffective, Accidental overdose, Fatigue, |
||||
ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, OXYCODONE, OXYCODONE, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, PREDNISONE, PREDNISONE, PREDNISONE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ERGOCALCIFEROL, MESALAMINE, CALCIUM CARBONATE, ANTACID, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, EPINEPHRINE HYDROCHLORIDE, CANDESARTAN CILEXETIL, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, INFLIXIMAB-DYYB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, VEDOLIZUMAB, VEDOLIZUMAB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MESALAMINE, MESALAMINE, RAMIPRIL, PRAVASTATIN SODIUM, MESALAMINE, MESALAMINE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, INFLIXIMAB-DYYB, ERGOCALCIFEROL, FESOTERODINE FUMARATE, |
||||
| 19 | 26941972 |
CA |
74 | |
Tooth extraction, Malignant melanoma, Arthralgia, Off label use, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 20 | 26942146 |
US |
37 | 1 |
Pruritus, Inappropriate schedule of product administration, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 21 | 26942186 |
CA |
20 | |
Rectal haemorrhage, Condition aggravated, Frequent bowel movements, Weight decreased, Weight increased, Off label use, Product dose omission issue, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 22 | 26942206 |
US |
75 | 1 |
Peripheral swelling, Arthralgia, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 23 | 26942217 |
US |
75 | 1 |
Hepatic pain, Inappropriate schedule of product administration, Diarrhoea, |
||||
ORAL SEMAGLUTIDE, |
||||
| 24 | 26942283 |
CA |
48 | |
Arthritis, Abscess, Fatigue, Swelling face, Weight increased, Infection, Oral candidiasis, Pain, Off label use, Intentional dose omission, Inappropriate schedule of product administration, Suspected off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 25 | 26942410 |
CA |
49 | |
Haematochezia, Condition aggravated, Weight decreased, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, |
||||
| 26 | 26942411 |
US |
2 | |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 27 | 26942436 |
US |
58 | 2 |
Exposure via skin contact, Accidental exposure to product, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 28 | 26942615 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, |
||||
| 29 | 26942694 |
CA |
45 | |
Colitis, Arthralgia, Weight decreased, Intentional product use issue, Off label use, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 30 | 26942753 |
US |
72 | 1 |
Rash, Dry skin, Pruritus, Inappropriate schedule of product administration, Periorbital swelling, Therapy cessation, Eye discharge, |
||||
IVERMECTIN, |
||||
| 31 | 26942807 |
US |
2 | |
Drug ineffective, Inappropriate schedule of product administration, |
||||
ORFORGLIPRON, ORFORGLIPRON, |
||||
| 32 | 26942921 |
US |
2 | |
Inappropriate schedule of product administration, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, |
||||
| 33 | 26943025 |
US |
71 | 1 |
Parkinson^s disease, Inappropriate schedule of product administration, Overdose, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, ISTRADEFYLLINE, |
||||
| 34 | 26943249 |
US |
2 | |
Infection, Inappropriate schedule of product administration, |
||||
DUPILUMAB, GUSELKUMAB, |
||||
| 35 | 26943447 |
US |
2 | |
Inappropriate schedule of product administration, Incorrect dose administered, Product complaint, |
||||
ALBUTEROL SULFATE, |
||||
| 36 | 26943617 |
1 | ||
Inappropriate schedule of product administration, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 37 | 26943639 |
JP |
1 | |
Neoplasm malignant, Polyp, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 38 | 26943727 |
US |
2 | |
Panic attack, Inappropriate schedule of product administration, Device use error, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 39 | 26943836 |
US |
31 | 2 |
Nausea, Vomiting, Inappropriate schedule of product administration, Abdominal distension, Feeding intolerance, Chest pain, Abdominal pain upper, Migraine, Dehydration, Chills, |
||||
| 40 | 26943898 |
CA |
52 | 2 |
Pyrexia, Oral infection, Peripheral swelling, Pain, Rash macular, Optic neuritis, Inappropriate schedule of product administration, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE, PREDNISONE, PREDNISONE, |
||||
| 41 | 26943919 |
CA |
38 | 2 |
Discomfort, Ear pruritus, Pharyngitis streptococcal, Throat irritation, Inappropriate schedule of product administration, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE, |
||||
| 42 | 26943945 |
CA |
68 | 2 |
COVID-19, Cough, Peripheral swelling, Pneumonia, Inappropriate schedule of product administration, |
||||
RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 43 | 26944060 |
US |
69 | 1 |
Pancreatic neoplasm, Diarrhoea, Inappropriate schedule of product administration, Flatulence, Faeces discoloured, Abnormal faeces, |
||||
PANCRELIPASE, |
||||
| 44 | 26944164 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 45 | 26944184 |
US |
73 | 2 |
Pneumonia, Inappropriate schedule of product administration, |
||||
SARILUMAB, SARILUMAB, |
||||
| 46 | 26944423 |
US |
2 | |
Lacrimation increased, Sinusitis, Inappropriate schedule of product administration, |
||||
LIFITEGRAST, LIFITEGRAST, |
||||
| 47 | 26944890 |
US |
62 | 2 |
Osteoporosis, Inappropriate schedule of product administration, Drug ineffective, |
||||
PREDNISONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, DENOSUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 48 | 26945069 |
US |
2 | |
Photophobia, Blood pressure decreased, Asthenia, Fatigue, Dizziness, Pain, Insomnia, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 49 | 26945091 |
US |
90 | 1 |
Inappropriate schedule of product administration, |
||||
INCLISIRAN, INCLISIRAN, INCLISIRAN, TELMISARTAN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FINASTERIDE, |
||||
| 50 | 26945722 |
CN |
78 | 2 |
Immune-mediated lung disease, Liver injury, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, CISPLATIN, |
||||
| 51 | 26945965 |
US |
2 | |
Blood iron increased, Hypertension, Muscle spasms, Orthostatic hypotension, Back pain, Malaise, Urticaria, Abdominal discomfort, Nausea, Fatigue, Pruritus, Circumstance or information capable of leading to medication error, Needle issue, Drug ineffective, Product dose omission issue, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CEFDINIR, PREDNISONE, CALCIUM, |
||||
| 52 | 26946034 |
US |
75 | 1 |
Injection site scar, Injection site haemorrhage, Injection site bruising, Product dose omission in error, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, |
||||
| 53 | 26946153 |
US |
67 | 2 |
Inappropriate schedule of product administration, Product dose omission issue, Product use issue, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 54 | 26946437 |
70 | 2 | |
Addison^s disease, Haematochezia, Inappropriate schedule of product administration, Intentional dose omission, Intentional product use issue, Malaise, Nausea, Pain, Therapeutic response shortened, Weight increased, |
||||
TRAMADOL HYDROCHLORIDE, INFLIXIMAB, |
||||
| 55 | 26947146 |
CA |
57 | |
Gastric bypass, Post procedural complication, Fear of injection, Product dose omission issue, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PANTOPRAZOLE, FAMOTIDINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 56 | 26948072 |
AU |
65 | 1 |
Suicidal ideation, Injection site erythema, Inappropriate schedule of product administration, Depression, Presyncope, Blood pressure systolic decreased, |
||||
ROZANOLIXIZUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 57 | 26948262 |
US |
75 | 1 |
Inappropriate schedule of product administration, Wrong technique in device usage process, Drug dose omission by device, Product dose omission in error, Device use issue, Device issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 58 | 26948268 |
CA |
53 | 1 |
Cardiac murmur, Inappropriate schedule of product administration, Colitis ulcerative, Off label use, Gamma-glutamyltransferase increased, Haematocrit decreased, Lymphocyte count decreased, Neutrophil count increased, Monocyte count decreased, Uterine leiomyoma, Red cell distribution width increased, Hypersensitivity, Red blood cell count decreased, Pneumonia, Blood cholesterol increased, Platelet count increased, Haemoglobin decreased, Abdominal lymphadenopathy, Mean cell haemoglobin concentration decreased, C-reactive protein increased, Product use in unapproved indication, Systemic lupus erythematosus, Condition aggravated, Pyrexia, Frequent bowel movements, Drug ineffective, Confusional state, Mean platelet volume decreased, Migraine, Depression, Stress, Haematochezia, Bronchiectasis, Headache, Fatigue, Hypopnoea, Pain in extremity, Rhinitis, Deep vein thrombosis, Eczema, Parosmia, Steroid dependence, Abdominal discomfort, Gingival pain, Alcohol poisoning, Somnolence, Tinnitus, Pulmonary embolism, Catarrh, Accidental overdose, COVID-19, Vertigo, Weight decreased, Burns second degree, Dysgeusia, Rectal haemorrhage, Arthritis, Swollen tongue, Tubulointerstitial nephritis, Palpitations, Cerebrovascular accident, Rash, Nightmare, Pain, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, WARFARIN, WARFARIN, PREDNISONE, PREDNISONE, PREDNISONE, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, ROSUVASTATIN, ROSUVASTATIN, EPINEPHRINE, ADRENALINUM, CANDESARTAN CILEXETIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, VEDOLIZUMAB, VEDOLIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OXYCODONE, OXYCODONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ERGOCALCIFEROL, MESALAMINE, CALCIUM CARBONATE, ANTACID, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, FESOTERODINE FUMARATE, |
||||
| 59 | 26934081 |
US |
66 | 1 |
Productive cough, Dyspnoea, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 60 | 26934083 |
CN |
75 | 1 |
Blood creatinine increased, Inappropriate schedule of product administration, Gouty arthritis, Condition aggravated, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 61 | 26934407 |
57 | 1 | |
Limb injury, Aphasia, Dysphagia, Speech disorder, Feeling drunk, Dizziness, Fatigue, Inappropriate schedule of product administration, Incorrect dose administered, |
||||
BRIVARACETAM, BRIVARACETAM INJECTION, BRIVARACETAM, BRIVARACETAM INJECTION, LACOSAMIDE, OXCARBAZEPINE, |
||||
| 62 | 26934567 |
CO |
80 | 1 |
Myocarditis, Inappropriate schedule of product administration, Blood cholesterol increased, Low density lipoprotein increased, Muscle atrophy, |
||||
EVOLOCUMAB, |
||||
| 63 | 26934831 |
US |
56 | 2 |
Inappropriate schedule of product administration, Hyperhidrosis, Weight increased, Abdominoplasty, Tremor, Drug ineffective, |
||||
| 64 | 26934843 |
US |
2 | |
Wrong technique in device usage process, Inappropriate schedule of product administration, |
||||
MEPOLIZUMAB, |
||||
| 65 | 26934860 |
US |
32 | 2 |
Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 66 | 26935058 |
CA |
42 | |
Fistula, Haematochezia, Harvey-Bradshaw index increased, Fall, Cough, Rhinorrhoea, Conjunctivitis, Herpes virus infection, Fatigue, Abdominal pain, Influenza, Off label use, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, IRON, VITAMIN C, |
||||
| 67 | 26935069 |
US |
37 | |
Product physical issue, Inappropriate schedule of product administration, Product storage issue, Off label use, |
||||
GUSELKUMAB, |
||||
| 68 | 26935082 |
KR |
2 | |
Hospitalisation, Red blood cell transfusion, Red blood cell transfusion, Radiotherapy, Inappropriate schedule of product administration, Inappropriate schedule of product administration, |
||||
PEGFILGRASTIM, PEGFILGRASTIM, |
||||
| 69 | 26935086 |
US |
7 | 2 |
Pruritus, Dry skin, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 70 | 26935300 |
KR |
||
Death, Inappropriate schedule of product administration, |
||||
SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, |
||||
| 71 | 26935493 |
US |
60 | 1 |
Abdominal distension, Constipation, Inappropriate schedule of product administration, |
||||
ORAL SEMAGLUTIDE, |
||||
| 72 | 26935592 |
US |
78 | 2 |
Blood glucose increased, Inappropriate schedule of product administration, Drug ineffective, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 73 | 26935600 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 74 | 26935802 |
US |
2 | |
Endometrial cancer, Inappropriate schedule of product administration, Psoriasis, Insurance issue, Therapy interrupted, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 75 | 26935905 |
US |
40 | 1 |
Autoimmune disorder, Inappropriate schedule of product administration, Condition aggravated, |
||||
ADALIMUMAB-ATTO, |
||||
| 76 | 26935982 |
US |
86 | 2 |
Urinary tract infection, Dysuria, Pollakiuria, Urine flow decreased, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 77 | 26936076 |
CA |
27 | 2 |
Crohn^s disease, Rhinorrhoea, Pruritus, Cough, Proctitis, Alopecia, Abscess, COVID-19, Rash macular, Peripheral swelling, Pyrexia, Inappropriate schedule of product administration, Off label use, |
||||
ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, |
||||
| 78 | 26936097 |
US |
65 | 2 |
Chemical burns of eye, Suspected product tampering, Inappropriate schedule of product administration, |
||||
| 79 | 26936566 |
US |
62 | 2 |
Inappropriate schedule of product administration, Drug ineffective, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 80 | 26936785 |
CA |
71 | |
Tooth extraction, Haematochezia, Weight increased, Weight decreased, Eczema, Rash macular, Abdominal pain, Refusal of treatment by patient, Condition aggravated, Incorrect dose administered, Product dose omission in error, Inappropriate schedule of product administration, Product dose omission issue, Off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ERGOCALCIFEROL, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 81 | 26936822 |
CA |
36 | 2 |
Dysphagia, Throat irritation, Oropharyngeal pain, Inappropriate schedule of product administration, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIMENHYDRINATE, METHYLPREDNISOLONE ACETATE, |
||||
| 82 | 26937083 |
US |
71 | 1 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 83 | 26937126 |
US |
8 | 2 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 84 | 26937308 |
CA |
23 | |
Pemphigoid, Psoriasis, Off label use, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, DAPSONE GEL, 5%, DAPSONE, DASPONE, |
||||
| 85 | 26937531 |
US |
1 | |
Inappropriate schedule of product administration, Multiple use of single-use product, |
||||
INSULIN GLARGINE, |
||||
| 86 | 26937568 |
US |
1 | |
Poor venous access, Inappropriate schedule of product administration, |
||||
ETEPLIRSEN, |
||||
| 87 | 26937642 |
CA |
52 | 2 |
Drug ineffective, Fatigue, Lower respiratory tract infection, Burning sensation, Tremor, Burning feet syndrome, Confusional state, Discomfort, Emotional disorder, Fear, Frustration tolerance decreased, Illness, Malaise, Mental disorder, Mobility decreased, Muscular weakness, Nightmare, Pain, Poor quality sleep, Post-traumatic stress disorder, Sleep disorder, Stress, Symptom recurrence, Chronic inflammatory demyelinating polyradiculoneuropathy, Off label use, Inappropriate schedule of product administration, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 88 | 26937898 |
US |
61 | 1 |
Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 89 | 26937957 |
2 | ||
Inappropriate schedule of product administration, Incorrect product administration duration, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 90 | 26937986 |
US |
50 | 1 |
Inappropriate schedule of product administration, Withdrawal syndrome, Depression, Confusional state, Cold sweat, Abdominal pain, Nausea, Frequent bowel movements, |
||||
LUMATEPERONE, LUMATEPERONE, LUMATEPERONE, LUMATEPERONE, |
||||
| 91 | 26938149 |
US |
41 | 2 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 92 | 26938326 |
US |
23 | 2 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 93 | 26938398 |
US |
67 | 2 |
Cataract, Alopecia, Inappropriate schedule of product administration, |
||||
FUTIBATINIB, LYTGOBI, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MOXIFLOXACIN HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PROCHLORPERAZINE MALEATE, |
||||
| 94 | 26938421 |
US |
51 | 2 |
Psoriatic arthropathy, Device malfunction, Product dose omission issue, Hidradenitis, Condition aggravated, Product leakage, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 95 | 26938559 |
68 | 1 | |
Musculoskeletal discomfort, Chest discomfort, Dyspnoea, Headache, Nausea, Inappropriate schedule of product administration, Drug monitoring procedure not performed, |
||||
IRON SUCROSE, IRON SUCROSE, |
||||
| 96 | 26938843 |
US |
||
Menstruation delayed, Inappropriate schedule of product administration, |
||||
DROSPIRENONE, |
||||
| 97 | 26938854 |
CA |
80 | 2 |
Oedema peripheral, Cardiac failure congestive, Dyspnoea, Grunting, Breath sounds abnormal, Cough, Secretion discharge, Dyspnoea, Weight decreased, Productive cough, Dyspnoea exertional, Joint swelling, Anxiety, Chest discomfort, Dyspnoea, Heart rate irregular, Oedema peripheral, Rales, Peripheral swelling, Obstructive airways disorder, Erythema, Rales, Oedema, Asthma, Inappropriate schedule of product administration, Off label use, Crepitations, Fatigue, Sleep disorder, |
||||
DUPILUMAB, DUPILUMAB, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, VALSARTAN, VALSARTAN ORAL, ALBUTEROL SULFATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, FUROSEMIDE, ACETYLCYSTEINE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 98 | 26938892 |
BR |
71 | 2 |
Asthmatic crisis, Inappropriate schedule of product administration, |
||||
BENRALIZUMAB, BENRALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 99 | 26939123 |
US |
2 | |
Cataract operation, Blood cholesterol abnormal, COVID-19, Oropharyngeal pain, Presbyopia, Arthralgia, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 100 | 26939349 |
US |
2 | |
Needle track marks, Injection site irritation, Chest discomfort, Dizziness, Injection site pain, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30